Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

27.72
Delayed Data
As of Sep 23
 +0.87 / +3.24%
Today’s Change
18.55
Today|||52-Week Range
225.54
-72.73%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
AssetsCash1.4B597.3M1.3B852.4M
 
 
 
 
 
Short Term Investment Cash409.6M-779.8M713.1M-449.8M
 
 
 
 
 
Cash & Short Term Investments1.4B613.3M1.3B853.4M
 
 
 
 
 
 
ReceivablesReceivables2.7B2.7B2.7B2.7B
 
 
 
 
 
 
InventoriesInventories1.2B1.3B1.3B1.3B
 
 
 
 
 
 
Current AssetsPrepaid Expenses--20.0M----
 
 
Other Current Assets1.7B930.4M894.4M895.8M
 
 
 
 
 
Current Assets7.0B5.5B6.2B5.8B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross1.4B2.6B----
 
 
 
Depreciation---1.2B----
 
 
Intangible Assets39.8B41.6B40.9B39.8B
 
 
 
 
 
Other Assets40.0B41.9B41.2B40.1B
 
 
 
 
 
Total Assets48.5B49.0B49.0B47.7B
 
 
 
 
 
 
LiabilitiesAccounts Payable476.8M433.7M438.1M425.9M
 
 
 
 
 
Short Term Debt707.0M838.5M675.1M294.1M
 
 
 
 
 
Accrued Expenses3.3B692.1M3.3B3.3B
 
 
 
 
 
Other Current Liabilities3.5B3.6B3.5B3.5B
 
 
 
 
 
Other Liabilities4.7B5.3B4.6B4.2B
 
 
 
 
 
 
Total LiabilitiesLong Term Debt30.2B30.3B31.3B30.8B
 
 
 
 
 
Deferred Taxes-5.9B-5.7B-5.7B-5.6B
 
 
 
 
 
Other Liabilities809.3M1.1B1.1B1.1B
 
 
 
 
 
Total Liabilities42.0B42.9B43.2B42.3B
 
 
 
 
 
 
EquityMinority Interest-2.2M-500.0K-800.0K-1.7M
 
 
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity6.3B5.9B5.7B5.3B
 
 
 
 
 
Total Shareholder Equity6.3B5.9B5.7B5.3B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding343.1M342.9M343.0M343.0M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.